Adjunctive treatment with interferon α-2b may decrease the risk of papilloma-associated conjunctival intraepithelial neoplasm recurrence

Cornea

Volumn 23, Issue 7, 2004, Pages 726-729

  Chen, Hung Chiao ^a   Chang, Shu Wen ^b,c,d   Huang, Shui Feng ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adjunctive therapy; Conjunctival intraepithelial neoplasm; Interferon; Papilloma virus; Recurrent

Indexed keywords

ALPHA2B INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ADULT; CASE REPORT; CONJUNCTIVA INTRAEPITHELIAL NEOPLASM; CONJUNCTIVA TUMOR; CORNEA LIMBUS; DRUG ADMINISTRATION ROUTE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; MALE; PERILESIONAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; TUMOR RECURRENCE; WART VIRUS;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA IN SITU; CHEMOTHERAPY, ADJUVANT; CONJUNCTIVAL NEOPLASMS; HUMANS; INJECTIONS, INTRALESIONAL; INTERFERON ALFA-2B; MALE; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRIDAE;

EID: 4744347310     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000126320.36014.d1     Document Type: Review

References (35)

1. Grossniklaus HE, Green WR, Luckenbach M, et al. Conjunctival lesions in adults: a clinical and histopathologic review. Cornea. 1987;6:78-116.
2. Pizzarello LD, Jakobiec FA. Bowen's disease of the conjunctiva: a misnomer. In: Jakobiec FA, ed. Ocular and Adnexal Tumors. Birmingham: Aesculapius; 1978:553-571.
3. Carroll J, Kuwabara T. A classification of limbal epitheliomas. Arch Ophthalmol. 1965;73:545-551.
4. Erie JC, Campbell RJ, Leisegang TJ. Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmology. 1986;93:176-183.
5. Cerezo L, Otero J, Aragon G, et al. Conjunctival intraepithelial and invasive squamous cell carcinoma treated with strontium-90. Radiother Oncol. 1990;17:191-197.
6. Danopoulos ED, Danopoulou IF, Liarikos SB, et al. Effects of urea treatment in malignancies of the conjunctiva and cornea. Ophthalmologica. 1979;178:198-203.
7. Yeatts RP, Ford JG, Stanton CA, et al. Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea. Ophthalmology. 1995; 102:1338-1344.
8. Herbort CP, Zografos L. Topical retinoic acid in dysplastic and metaplastic keratinization of corneoconjunctival epithelium. Graefes Arch Clin Exp Ophthalmol. 1998;266:22-26.
9. Papandroudis AA, Dimitrakos SA, Stangos NT. Mitomycin C therapy for conjunctival-corneal intraepithelial neoplasia. Cornea. 2002;21:715-717.
10. Karp CL, Moore JK. Rosa RH Jr. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmology. 2001;108:1093-1098.
11. Schechter BA, Schrier A, Nagler RS, et al. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Cornea. 2002;21:6-11.
12. Vann RR, Karp CL. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. Ophthalmology. 1999;106:91-97.
13. Maskin SL. Regression of limbal epithelial dysplasia with topical interferon. Arch Ophthalmol. 1994;112:1145-1146.
14. Hu FR, Wu MJ, Kuo SH. Interferon treatment for corneolimbal squamous dysplasia. Am J Ophthalmol. 1998;125:118-119.
15. Kobayashi A, Yoshita T, Uchiyama K, et al. Successful management of conjunctival intraepithelial neoplasia by interferon alpha-2b. Jpn J Ophthalmol. 2002;46:215-217.
16. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol. 1995;39:429-450.
17. McGavic JS. Intraepithelial epithelioma of the corneal and conjunctiva (Bowen's disease). Am J Ophthalmol. 1942;25:167-176.
18. Erie JC, Campbell RJ, Liesegang TJ. Conjunctival and corneal intraepithelial neoplasia. Ophthalmology. 1986;93:176-183.
19. Tabin G, Levin S, Snibson G, et al. Late recurrence and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. Ophthalmology. 1997;104:485-492.
20. Tune M, Char DH, Crawford B, et al. Intraepithelial and invasive squamous cell carcinoma of the conjunctiva: analysis of 60 cases. Br J Ophthalmol. 1999;83:98-103.
21. Chute CG, Chuang TY, Bergstralh EJ, et al. The subsequent risk of internal cancer with Bowen's disease. JAMA. 1991;266:816-819.
22. Newton R, Ferlay J, Reeves G, et al. Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma of the eye. Lancet. 1996;347:1450-1451.
23. Waddell KM, Lewallen S, Lucas SB, et al. Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Br J Ophthalmol. 1996;80: 503-508.
24. Lee GA, Williams G, Hirst LW, et al. Risk factors in the development of ocular surface epithelial dysplasia. Ophthalmology. 1994;101:360-364.
25. Newton R. A review of the etiology of squamous cell carcinoma of the conjunctiva. Br J Cancer. 1996;74:1511-1513.
26. Scott IU, Karp CL, Nuovo GJ. Human papillomavirus 16 and 18 expression in conjunctival intraepithelial neoplasia. Ophthalmology. 2002;109: 542-547.
27. Saegusa M, Takano Y, Hashimura M, et al. HPV type 16 in conjunctival and junctional papilloma, dysplasia, and squamous cell carcinoma. J Clin Pathol. 1995;48:1106-1110.
28. McDonnell JM, McDonnell PJ, Sun YY. Human papillomavirus DNA in tissues and ocular surface swabs of patients with conjunctival epithelial neoplasia. Invest Ophthalmol Vis Sci 1992;33:184-189.
29. Tulvatana W, Bhattarakosol P, Sansopha L, et al. Risk factors for conjunctival squamous cell neoplasia: a matched case-control study. Br J Ophthalmol. 2003;87:396-398.
30. Karcioglu ZA, Issa TM. Human papilloma virus in neoplastic and non-neoplastic conditions of the external eye. Br J Ophthalmol. 1997;81:595-598.
31. Odrich MG, Jakobiec FA, Lancaster WD, et al. A spectrum of bilateral squamous conjunctival tumors associated with human papilloma virus typelo. Ophthalmology. 1991;98:628-635.
32. Tritten JJ, Beati D, Sahli R, et al. Bilateral conjunctivo-palpebral tumor in an immunocompetent man cause by human papilloma virus. Klin Monatsbl Augenheilkd. 1994;204:453-455.
33. Baron S, Tyring SK, Fleischmann WR, et al. The interferons: mechanisms of action and clinical applications. JAMA. 1991;266:375-383.
34. Kawano T, Shigehira M, Nakama T, et al. Retinal complication during interferon therapy for chronic hepatitis C. Am J Ophthalmol. 1996;91: 309-313.
35. Gupta R, Singh S, Tang R, et al. Anterior ischemic optic neuropathy caused by interferon alpha therapy. Am J Med. 2002;112:683-684.